ArticleMolecular cancer2022

Costunolide is a dual inhibitor of MEK1 and AKT1/2 that overcomes osimertinib resistance in lung cancer.

Xueli Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.